Japan vs New Zealand: Previously treated cases tested for RR-/MDR-TB
Japan
58.0%
in 2024
New Zealand
58.0%
in 2014
Japan rank
140th
New Zealand rank
140th
Previously treated cases tested for RR-/MDR-TB over time
- Japan
- New Zealand
How they compare
Japan currently reports 58.0% against 58.0% in New Zealand, a difference of 0.0%.
Across all 5 years both countries report, New Zealand has been ahead every year.
Japan ranks 140th and New Zealand ranks 140th of 180 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.0% | 47.0% | 21.0% | New Zealand |
| 2010s | 41.0% | 78.0% | 37.0% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Japan or New Zealand?
- Japan, at 58.0% against 58.0% in New Zealand as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Japan and New Zealand?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and New Zealand?
- 5 years are reported by both, from 2007 to 2014.
- How do Japan and New Zealand rank globally for previously treated cases tested for rr-/mdr-tb?
- Japan ranks 140th and New Zealand ranks 140th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.